| scholarly article | Q13442814 |
| P50 | author | Nikunj Maniyar | Q117195104 |
| Sujata Yerwadekar | Q117195124 | ||
| Gargi S. Sarode | Q39432650 | ||
| Sachin C. Sarode | Q39432687 | ||
| Nilesh Kumar Sharma | Q41514241 | ||
| P2093 | author name string | Shankargouda Patil | |
| P2860 | cites work | Upregulation of miR-31* is negatively associated with recurrent/newly formed oral leukoplakia | Q21134532 |
| A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma | Q24322614 | ||
| The potential role of podoplanin in tumour invasion | Q24653540 | ||
| Molecular pathways: fibroblast growth factor signaling: a new therapeutic opportunity in cancer | Q26824059 | ||
| Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 | Q27860674 | ||
| Six genes expressed in bones and teeth encode the current members of the SIBLING family of proteins | Q28204658 | ||
| Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma | Q28259466 | ||
| Cross-class inhibition of the cysteine proteinases cathepsins K, L, and S by the serpin squamous cell carcinoma antigen 1: a kinetic analysis | Q28268059 | ||
| Receptors for fibroblast growth factors | Q28285082 | ||
| Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells | Q28302950 | ||
| Phospholipase Cgamma1 is required for metastasis development and progression | Q28303679 | ||
| Molecular mechanisms and clinical applications of angiogenesis | Q29547314 | ||
| The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype | Q29615563 | ||
| Molecular requirements for epithelial-mesenchymal transition during tumor progression | Q29618960 | ||
| Polycomb silencers control cell fate, development and cancer | Q29619697 | ||
| Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma | Q29620604 | ||
| Two members of the SIBLING family of proteins, DSPP and BSP, may predict the transition of oral epithelial dysplasia to oral squamous cell carcinoma | Q33759345 | ||
| Epidermal growth factor receptor expression and gene copy number in the risk of oral cancer | Q33976619 | ||
| Expression of basic fibroblast growth factor in squamous cell carcinoma of the head and neck is associated with degree of histologic differentiation | Q71891231 | ||
| Low-dose isotretinoin versus beta-carotene to prevent oral carcinogenesis: long-term follow-up | Q73031816 | ||
| Immunohistochemical localization of growth factors fibroblast growth factor-1 and fibroblast growth factor-2 and receptors fibroblast growth factor receptor-2 and fibroblast growth factor receptor-3 in normal oral epithelium, epithelial dysplasias, | Q74328108 | ||
| HERG K+ channel, a regulator of tumor cell apoptosis and proliferation | Q74710805 | ||
| A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors | Q74754458 | ||
| Genome-wide profiling of oral squamous cell carcinoma | Q80573626 | ||
| Recent advances in head and neck cancer | Q81950649 | ||
| Two stem cell markers, ATP-binding cassette, G2 subfamily (ABCG2) and BMI-1, predict the transformation of oral leukoplakia to cancer: a long-term follow-up study | Q82086439 | ||
| Podoplanin and ABCG2: malignant transformation risk markers for oral lichen planus | Q83120458 | ||
| Early stage squamous cell cancer of the oral tongue--clinicopathologic features affecting outcome | Q84475395 | ||
| Phospholipase C-gamma1 is required for the epidermal growth factor receptor-induced squamous cell carcinoma cell mitogenesis | Q33982851 | ||
| Physiology of EAG K+ channels | Q34293359 | ||
| Mechanisms underlying differential responses to FGF signaling | Q34415005 | ||
| Progression of oral squamous cell carcinoma accompanied with reduced E-cadherin expression but not cadherin switch. | Q34460713 | ||
| SERPINB3 (serpin peptidase inhibitor, clade B (ovalbumin), member 3). | Q34476786 | ||
| Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy | Q34655667 | ||
| Disease-associated miRNA-mRNA networks in oral lichen planus. | Q34749209 | ||
| Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. | Q34981591 | ||
| E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study. | Q34995122 | ||
| Phospholipase C-gamma1 in tumor progression. | Q35175975 | ||
| Cell adhesion and signalling by cadherins and Ig-CAMs in cancer | Q35667465 | ||
| Focus on head and neck cancer | Q35749406 | ||
| Histological and culture studies with respect to ABCG2 expression support the existence of a cancer cell hierarchy in human hepatocellular carcinoma | Q35757248 | ||
| Fibroblast Growth Factor (FGF-2) and Its Receptors FGFR-2 and FGFR-3 May Be Putative Biomarkers of Malignant Transformation of Potentially Malignant Oral Lesions into Oral Squamous Cell Carcinoma | Q35806543 | ||
| Post-transcriptional homeostasis and regulation of MCM2-7 in mammalian cells | Q36008189 | ||
| Ion channels and cancer | Q36345954 | ||
| A dual receptor system is required for basic fibroblast growth factor activity | Q36428185 | ||
| Association of Decreased Expression of Serum miR-9 with Poor Prognosis of Oral Squamous Cell Carcinoma Patients | Q36525513 | ||
| Potential involvement of miR-375 in the premalignant progression of oral squamous cell carcinoma mediated via transcription factor KLF5. | Q36545576 | ||
| A minimally invasive immunocytochemical approach to early detection of oral squamous cell carcinoma and dysplasia | Q36614077 | ||
| Cadherins in development: cell adhesion, sorting, and tissue morphogenesis | Q36678732 | ||
| Expression of Mcm2, geminin and Ki67 in normal oral mucosa, oral epithelial dysplasias and their corresponding squamous-cell carcinomas | Q37160638 | ||
| DeltaNp63 overexpression, alone and in combination with other biomarkers, predicts the development of oral cancer in patients with leukoplakia | Q37373276 | ||
| CD133 as a marker for cancer stem cells: progresses and concerns | Q37466745 | ||
| ATP binding and hydrolysis by Mcm2 regulate DNA binding by Mcm complexes | Q37500135 | ||
| Aldehyde dehydrogenase: its role as a cancer stem cell marker comes down to the specific isoform | Q37873272 | ||
| Cadherins in collective cell migration of mesenchymal cells | Q38040276 | ||
| Podoplanin--a novel marker in oral carcinogenesis | Q38223220 | ||
| HERG1 potassium channel expression in potentially malignant disorders of the oral mucosa and prognostic relevance in oral squamous cell carcinoma. | Q51768648 | ||
| MicroRNA-375 as a biomarker for malignant transformation in oral lesions. | Q51776663 | ||
| Immunohistochemical analyses of survivin and heat shock protein 90 expression in patients with oral lichen planus. | Q51840906 | ||
| Expression of cadherins and catenins in oral epithelial dysplasia and squamous cell carcinoma. | Q52531723 | ||
| Salivary microRNAs in oral cancer. | Q52958113 | ||
| MCM3 could be a better marker than Ki-67 for evaluation of dysplastic oral lesions: an immunohistochemical study. | Q54382587 | ||
| hERG1 channels in human esophagus: evidence for their aberrant expression in the malignant progression of Barrett's esophagus. | Q54589264 | ||
| Survivin, a Potential Early Predictor of Tumor Progression in the Oral Mucosa | Q57765196 | ||
| A Comprehensive Expression Analysis of Cancer Testis Antigens in Head and Neck Squamous Cell Carcinoma Revels MAGEA3/6 as a Marker for Recurrence | Q61758599 | ||
| Oral leukoplakia and malignant transformation. A follow-up study of 257 patients | Q70788858 | ||
| A novel inward-rectifying K+ current with a cell-cycle dependence governs the resting potential of mammalian neuroblastoma cells | Q71629458 | ||
| Immunocytochemical localization of fibroblast growth factor-1 (FGF-1) and FGF-2 in oral squamous cell carcinoma (SCC) | Q71674614 | ||
| Oral potentially malignant disorders: A proposal for terminology and definition with review of literature | Q38264410 | ||
| Functional up-regulation of HERG K+ channels in neoplastic hematopoietic cells | Q38291180 | ||
| Up-regulation of SIBLING proteins and correlation with cognate MMP expression in oral cancer. | Q38433883 | ||
| Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival | Q38434830 | ||
| A panel of microRNAs can be used to determine oral squamous cell carcinoma. | Q38781631 | ||
| MicroRNAs as a Novel Class of Diagnostic Biomarkers in Detection of Oral Carcinoma: a Meta-Analysis Study | Q38828514 | ||
| ALDH1 and podoplanin expression patterns predict the risk of malignant transformation in oral leukoplakia | Q38998641 | ||
| E-cadherin downregulation and Twist overexpression since early stages of oral carcinogenesis | Q39138727 | ||
| Role of HERG1 potassium channel in both malignant transformation and disease progression in head and neck carcinomas. | Q39372092 | ||
| Expression deregulation of mir31 and CXCL12 in two types of oral precancers and cancer: importance in progression of precancer and cancer | Q39420865 | ||
| Evaluation of survivin as a prognostic marker in oral squamous cell carcinoma | Q39755799 | ||
| Inhibition of tumorigenicity and enhancement of radiochemosensitivity in head and neck squamous cell cancer-derived ALDH1-positive cells by knockdown of Bmi-1. | Q39758633 | ||
| Grading oral epithelial dysplasia: analysis of individual features | Q39759600 | ||
| Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells. | Q39794629 | ||
| Side population in oral squamous cell carcinoma possesses tumor stem cell phenotypes | Q39888605 | ||
| Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neck | Q39913253 | ||
| Identification of human aldehyde dehydrogenase 1 family member A1 as a novel CD8+ T-cell-defined tumor antigen in squamous cell carcinoma of the head and neck | Q40059136 | ||
| SERPINB3 protects from oxidative damage by chemotherapeutics through inhibition of mitochondrial respiratory complex I. | Q40720441 | ||
| Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma | Q40808781 | ||
| Biological roles of fibroblast growth factor-2. | Q41349632 | ||
| MicroRNAs-208b-3p, 204-5p, 129-2-3p and 3065-5p as predictive markers of oral leukoplakia that progress to cancer | Q42388428 | ||
| E-cadherin, laminin and collagen IV expression in the evolution from dysplasia to oral squamous cell carcinoma. | Q42491426 | ||
| Identification of a novel cell-cycle-induced MCM family protein MCM9. | Q42815482 | ||
| The expression of Ki-67, MCM3, and p27 defines distinct subsets of proliferating, resting, and differentiated cells. | Q42822936 | ||
| Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival | Q44407580 | ||
| A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy | Q45279024 | ||
| Expression patterns of cancer stem cell markers ALDH1 and CD133 correlate with a high risk of malignant transformation of oral leukoplakia | Q45396030 | ||
| Functional genomic analysis identified epidermal growth factor receptor activation as the most common genetic event in oral squamous cell carcinoma | Q46093042 | ||
| Clinical significance of genetic alterations and expression of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinomas | Q46127298 | ||
| Phospholipase C-γ1 expression correlated with cancer progression of potentially malignant oral lesions | Q47659277 | ||
| Cytokines and tumor markers in potentially malignant disorders and oral squamous cell carcinoma: a pilot study | Q47999156 | ||
| Genetic variants in microRNA-146a (C>G) and microRNA-1269b (G>C) are associated with the decreased risk of oral premalignant lesions, oral cancer, and pharyngeal cancer | Q48037918 | ||
| MicroRNA-31 upregulation predicts increased risk of progression of oral potentially malignant disorder | Q48068485 | ||
| herg encodes a K+ current highly conserved in tumors of different histogenesis: a selective advantage for cancer cells? | Q48945547 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 424 | |
| P577 | publication date | 2019-07-01 | |
| P1433 | published in | Oncology reviews | Q26841967 |
| P1476 | title | Recent trends in predictive biomarkers for determining malignant potential of oral potentially malignant disorders | |
| P478 | volume | 13 |
Search more.